Literature DB >> 28003110

Eosinophilic pneumonia caused by daptomycin: Six cases from two institutions and a review of the literature.

Jun Hirai1, Mao Hagihara2, Shusaku Haranaga3, Takeshi Kinjo3, Hiroe Hashioka3, Hideo Kato2, Daisuke Sakanashi2, Yuka Yamagishi4, Hiroshige Mikamo4, Jiro Fujita3.   

Abstract

Here we report six cases of daptomycin (DAP)-induced eosinophilic pneumonia (DIEP) encountered at two medical centers and present a review of 43 DIEP patients from 26 studies to compare the clinical characteristics and radiographic findings of acute and chronic eosinophilic pneumonia (AEP; CEP). Four of the six patients did not exhibit respiratory symptoms, and one patient with only fever was misdiagnosed with DAP-induced fever. According to our literature review and the present findings, male sex and old age were dominant risk factors for DIEP. Fever and fine crackles were the most common clinical manifestations. The DAP dose and duration of administration were not significant risk factors for DIEP, and we also could not find any association between allergic predisposition and DIEP. Among the reviewed patients, 51.8% did not show more than 25% eosinophils in bronchoalveolar lavage, which is a criterion for the diagnosis of drug-induced eosinophilic pneumonia. Chest images of all patients showed CEP patterns such as multiple reticulonodular infiltrates in the subpleural region and diffuse bilateral pulmonary infiltrates with ground-glass opacities. However, 66.7% of patients also exhibited pleural effusion, a feature specific to AEP. All patients showed prompt recovery after DAP withdrawal. Our results suggest that clinicians should consider DIEP as a differential diagnosis when patients receiving DAP therapy, particularly men and elderly patients, present with fever, even in the absence of respiratory symptoms. Furthermore, they should be aware that the occurrence of DIEP is independent of the DAP dose and administration duration, and allergic reaction.
Copyright © 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute eosinophilic pneumonia; Chronic eosinophilic pneumonia; Daptomycin; Elderly; Eosinophilic pneumonia; Male sex

Mesh:

Substances:

Year:  2016        PMID: 28003110     DOI: 10.1016/j.jiac.2016.09.001

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  4 in total

Review 1.  Drug-induced eosinophilic pneumonia: A review of 196 case reports.

Authors:  Carmi Bartal; Iftach Sagy; Leonid Barski
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

2.  Daptomycin associated eosinophilic pneumonia: case report and differential diagnoses.

Authors:  Sijan Basnet; Niranjan Tachamo; Rashmi Dhital; Biswaraj Tharu
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-06-12

3.  Daptomycin eosinophilic pneumonia: an adverse effect to be aware of.

Authors:  G Abelenda Alonso; I Montes Rodríguez; J Martín Torres; P Del Valle Loarte
Journal:  Rev Esp Quimioter       Date:  2018-05-22       Impact factor: 1.553

4.  Risk Factors of Daptomycin-Induced Eosinophilic Pneumonia in a Population with Osteoarticular Infection.

Authors:  Laura Soldevila-Boixader; Bernat Villanueva; Marta Ulldemolins; Eva Benavent; Ariadna Padulles; Alba Ribera; Irene Borras; Javier Ariza; Oscar Murillo
Journal:  Antibiotics (Basel)       Date:  2021-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.